Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Xavier Rossello, Antonio Piñero, Rodrigo Fernández-Jiménez, Javier Sánchez-González, Gonzalo Pizarro, Carlos Galán-Arriola, Manuel Lobo-Gonzalez, Jean Paul Vilchez, Jaime García-Prieto, Jose Manuel García-Ruiz, Ana García-Álvarez, David Sanz-Rosa, Borja Ibanez
Research output: Contribution to journal › Article › peer-review
8Scopus
citations
Fingerprint
Dive into the research topics of 'Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction'. Together they form a unique fingerprint.